DIA 2012 Annual Meeting featured the most comprehensive educational platform for the pharmaceutical, biotechnology, medical device, and related fields. The top 10 sessions from the 2012 agenda are now available for only $399. The sessions cover today’s hottest topics, such as PDUFA V, social media, international and region-specific content, and much more! Check out all the special topics that were covered at DIA 2012.

Sessions included:
161 Analysis and Impact of PDUFA V: How the Changes Will Affect the Work of Regulatory Affairs Professionals
120 European Town Hall: Part 1 of 2 - Hot Topics in Europe
148 European Town Hall: Part 2 of 2 - Interacting With the European System
116 The Impact of Social Media on Product Promotion and Pharmacovigilance
139 Regulatory Collaboration / 21st Century Innovation: Views of the Heads of Health Canada, the European Medicines Agency, and the US FDA
215 Understanding Risk-based Monitoring: Is It Art, Science, or Both?
245 Collaborative Partnerships in Drug Development: An Executive Roundtable Discussion
318 Auditing Pharmaceutical Quality Systems
413 CDER Town Hall: Part 1 of 2
425 CDER Town Hall: Part 2 of 2